Medscape Medical News
Sep 29, 2013
AMSTERDAM — To the ongoing debate over whether routine screening for
prostate cancer reduces prostate cancer mortality comes a new analysis
that suggests that it does more harm than good.
The total harms that men experience in terms of impotence,
incontinence, and other side effects from prostate cancer treatment can
severely affect their quality of life, lead author Mathieu Boniol, MD,
said here at the European Cancer Conference 2013 (ECCO-ESMO-ESTRO).
Dr. Boniol and colleagues conducted a systematic review of the
literature for data on results of prostate-specific antigen (PSA)
testing, biopsy rates, and mortality/associated side effects from
radical prostatectomy, as well as hospitalization rates associated with
biopsy. They also used data from the European Randomized Study of
Screening for Prostate Cancer, which is the study showing the most
favorable outcomes for PSA screening.
Read the full Medscape Medical News report
(free sign-up may be required)
Tuesday, October 1, 2013
Testosterone Therapy: Scant Evidence of Benefit in CVD Risk
Medscape Medical News
Sep 25, 2013
Although there is some evidence that low endogenous testosterone levels may be linked to cardiovascular risk, a review of the last 43 years of literature finds scant definitive evidence that testosterone supplementation affects that risk.
Johannes B. Ruige, MD, PhD, from the Department of Endocrinology, Ghent University Hospital, Belgium, and colleagues. report their findings in an article published online September 24 in the Journal of Clinical Endocrinology & Metabolism.
Read the full Mescape Medical News report
(free sign-up may be required)
Sep 25, 2013
Although there is some evidence that low endogenous testosterone levels may be linked to cardiovascular risk, a review of the last 43 years of literature finds scant definitive evidence that testosterone supplementation affects that risk.
Johannes B. Ruige, MD, PhD, from the Department of Endocrinology, Ghent University Hospital, Belgium, and colleagues. report their findings in an article published online September 24 in the Journal of Clinical Endocrinology & Metabolism.
Read the full Mescape Medical News report
(free sign-up may be required)
Subscribe to:
Posts (Atom)